Scientists have discovered the hidden signals in the blood of pregnant women, and they can identify signals of postpartum depression within a few months before the symptoms appear. This discovery brought hope to 10-15 % of new mothers.
The research team of Weill Cornell Medicine and Virginia found that molecules derived from specific hormones in specific hormones in three -year -old blood samples can indicate which women may have depression after childbirth. Their discovery appeared in the latest issue of neurosciences.
“Postpartum is the only one in people’s life. We know that there are biological triggers, and people who can ensure that a certain percentage will be sick.” “If we can solve this biology and find prediction factors for it, we will not only help women not only help women And can improve us to try to find other psychiatric prediction factors. “
The group focuses on molecules called neurological steroids. These molecules are derived from progesterone and progesterone and affect the brain’s pressure response and emotional regulation. Their research on 136 women found that later people with postpartum depression showed different patterns in these molecules during pregnancy.
It may be of great significance to medical care for maternals. At present, after the symptoms are diagnosed, depression is diagnosed, and when many new mothers are struggling with emotional difficulties, fatigue and bonds with babies.
Dr. Jennifer Payne, a co -leader at the University of Virginia, emphasized the unique opportunity provided by this opportunity. She said: “Studying postpartum depression makes us have a way to recognize the biological changes that occur before someone becomes frustrated, because the timing of postpartum depression can be predicted.”
Two specific molecules appear as key participants: pregnancy ketone, which helps to calm the brain’s pressure response, as well as increasing the pressure of heterol. Women with postpartum depression show the imbalances of these molecules in three months.
This discovery is very consistent with the recent approval of new therapy for postpartum depression. Dr. OSBORNE said: “We don’t know if these drugs can be used as preventive measures for people with risk of postpartum depression, but according to our discovery, they may prevent postpartum depression.”
Looking forward to the future, researchers plan to verify their discovery in a larger and diverse patient group. They also measured the situation of the progesterone pathway before the postpartum depression before giving metering a specific enzyme level in various forms of specific enzyme levels.
The development of predictive blood tests may change the psychological health care of pregnant women, enabling doctors to be able to identify and support high -risk mothers in the face of challenging symptoms and neonatal care. For millions of families affected by postpartum depression each year, this prevention method may have a important difference in the important few months of parents.
If you find this work useful, consider supporting our work through one -time or monthly donations. Your contribution allows us to continue to bring you the accuracy that you can trust, and to be deeply scientific and medical news. Independent reports take time, energy and resources, and your support makes us likely to continue to explore stories important to you. Together, we can ensure that important discoveries and development attracts them the most.
